Precision Cancer Therapies, Volume 1: Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice

Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice is a comprehensive reference work that focuses on precision cancer therapies related to lymphoma. It covers key topics such as the biological basis of lymphoid malignancies, programmed cell death, the PI3K pathway, the cancer epigenome, and the tumor proteome. The book is written for scientists and physicians in the public and private sectors and aims to bridge the gap between basic and applied science.

Format: Hardback
Length: 512 pages
Publication date: 04 May 2023
Publisher: John Wiley and Sons Ltd

Lymphoid malignancies, a complex group of diseases, have witnessed remarkable advancements in precision cancer therapies. Targeting oncogenic drivers and signaling pathways has emerged as a key strategy in this field. In this comprehensive compilation, we delve into the latest scientific breakthroughs related to lymphoma.

The book is organized into distinct sections, each dedicated to a specific biology or class of drugs. Each section begins with an introductory chapter authored by an esteemed authority in the field, providing a deep understanding of the science and its significance in cancer biology. This approach ensures that scientists, physicians, and the private sector gain a comprehensive grasp of the extraordinary advances that have led to significant progress in the disease.

The primary focus of the work lies in translating fundamental principles of basic science into information that can directly benefit patients. Hence, the subtitle, "From Concept to Practice." To enhance readers' comprehension, the first page of each chapter features a box titled "Take Home Points." This concise summary will highlight the key unique insights contained within the chapter.

Some of the critical topics addressed in this work include:

Biological Basis of Lymphoid Malignancies: Fundamental principles of lymphomagenesis and molecular classification of lymphoid malignancies.

Targeting Programmed Cell Death: Understanding the diverse types of cell death and exploring promising drug combinations targeting apoptosis.

Targeting the PI3K Pathway: Delving into the complexities of this intricate biology and exploring how targeted drugs can be effectively leveraged therapeutically.

By presenting these topics in a comprehensive and accessible manner, this book serves as a valuable resource for researchers, physicians, and healthcare professionals seeking to advance their understanding of lymphoma and develop innovative precision cancer therapies.

Weight: 1616g
Dimension: 280 x 217 x 32 (mm)
ISBN-13: 9781119819929